GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » Cyclically Adjusted Book per Share

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Cyclically Adjusted Book per Share : ¥6.11 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shenzhenlubris Pharmaceuticals Co's adjusted book value per share for the three months ended in Mar. 2024 was ¥7.379. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥6.11 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Shenzhenlubris Pharmaceuticals Co's average Cyclically Adjusted Book Growth Rate was 6.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shenzhenlubris Pharmaceuticals Co was 14.60% per year. The lowest was 9.20% per year. And the median was 10.85% per year.

As of today (2024-06-10), Shenzhenlubris Pharmaceuticals Co's current stock price is ¥27.26. Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥6.11. Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is 4.46.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shenzhenlubris Pharmaceuticals Co was 14.25. The lowest was 4.08. And the median was 5.81.


Shenzhenlubris Pharmaceuticals Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co Cyclically Adjusted Book per Share Chart

Shenzhenlubris Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.24 4.60 5.10 5.62 5.99

Shenzhenlubris Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.73 5.80 5.93 5.99 6.11

Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted PB Ratio falls into.



Shenzhenlubris Pharmaceuticals Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shenzhenlubris Pharmaceuticals Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=7.379/115.2271*115.2271
=7.379

Current CPI (Mar. 2024) = 115.2271.

Shenzhenlubris Pharmaceuticals Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.090 98.200 3.626
201409 3.335 98.900 3.886
201412 3.613 99.000 4.205
201503 3.914 99.900 4.515
201506 3.768 99.500 4.364
201509 4.063 100.500 4.658
201512 4.388 100.600 5.026
201603 4.729 102.200 5.332
201606 4.451 101.400 5.058
201609 4.781 102.400 5.380
201612 5.124 102.600 5.755
201703 5.484 103.200 6.123
201706 5.119 103.100 5.721
201709 5.465 104.100 6.049
201712 5.787 104.500 6.381
201803 6.181 105.300 6.764
201806 5.740 104.900 6.305
201809 6.090 106.600 6.583
201812 6.365 106.500 6.887
201903 6.675 107.700 7.142
201906 6.173 107.700 6.604
201909 6.256 109.800 6.565
201912 6.204 111.200 6.429
202003 6.221 112.300 6.383
202006 5.482 110.400 5.722
202009 5.534 111.700 5.709
202012 5.266 111.500 5.442
202103 5.083 112.662 5.199
202106 7.236 111.769 7.460
202109 7.135 112.215 7.326
202112 7.206 113.108 7.341
202203 7.214 114.335 7.270
202206 6.881 114.558 6.921
202209 7.016 115.339 7.009
202212 7.123 115.116 7.130
202303 7.312 115.116 7.319
202306 6.965 114.558 7.006
202309 7.095 115.339 7.088
202312 7.193 114.781 7.221
202403 7.379 115.227 7.379

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Shenzhenlubris Pharmaceuticals Co  (SZSE:002294) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=27.26/6.11
=4.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shenzhenlubris Pharmaceuticals Co was 14.25. The lowest was 4.08. And the median was 5.81.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shenzhenlubris Pharmaceuticals Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description

Traded in Other Exchanges
N/A
Address
1901 Chuangzhan Center, 6007 Shennan Road, Futian District, Shenzhen, CHN
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.
Executives
Yan Jie Directors, executives
Yang Jian Feng Secretary, Director
Zhao Song Ping Executives
Liu Jun Executives
Li Ai Zhen Supervisors
Chen Ping Executives
Ye Cheng Hai Director
Lu Feng Executives, directors
Chen Qiong Xing Supervisors
Li Ying Hui Supervisors
Pan Ling Man Independent director
Zhang Zhong Xing Executives

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Headlines

No Headlines